組織バンキング市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

組織バンキング市場は、2023年に338億1,000万米ドルと評価され、2024年には371億3,000万米ドルに達すると予測され、CAGR 9.91％で成長し、2030年には655億4,000万米ドルに達すると予測されています。

調査対象範囲と定義は、治療および研究目的のためのヒト組織の収集、加工、保存、流通を包含します。このプロセスは、再生医療、がん治療、移植などの用途に極めて重要であり、生物医学研究において重要な資源として機能します。組織バンクは、品質と安全基準を満たした組織をタイムリーに入手できるようにする上で、重要な役割を果たしています。最終用途の範囲には、病院、研究機関、バイオ製薬会社などが含まれ、それぞれ患者の直接治療から先端医療研究、新規治療法の開発まで、特定の用途のために組織を利用しています。

組織バンキング市場に影響を与える主な成長要因には、バイオテクノロジーの進歩、再生医療に対する需要の増加、高度な治療ソリューションが必要とされる慢性疾患の有病率の上昇などがあります。組織ベースの研究を促進する政府の取り組みや製薬会社による研究開発投資の増加が、この成長をさらに後押ししています。注目すべきビジネスチャンスは、ヘルスケア・インフラの改善と組織提供に対する意識の高まりに後押しされ、拡大する新興市場にあります。これを活用するために、企業は費用対効果が高く効率的な組織保存技術の開発、組織工学製品の信頼性向上、学術・研究機関との戦略的提携に注力すべきです。

市場成長に影響を与える課題には、組織バンキングの事業を管理する厳しい規制の枠組みや、組織提供や使用に関する倫理的な懸念などがあります。組織の保存と長期保存における技術的なハードルも大きな課題となっています。凍結保存法の革新、組織処理の自動化、データ管理のためのバイオバンキングソフトウェアの開発は、研究と事業成長のための有望な分野を提示しています。

この市場は、規制や倫理的配慮と急速な技術進歩が複雑に絡み合っているのが特徴です。そのため、企業は最先端の研究開発に投資する一方で、規制基準の遵守を優先しなければならないです。規制機関との協力、研修への投資、組織提供に関する一般向け啓発キャンペーンなどは、市場拡大を促進し、現在の限界に対処するために推奨される戦略です。

市場力学：急速に進化する組織バンキング市場の主要市場インサイトを公開

組織バンキング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • バイオバンクの世界の増加
  • ヘルスケア機関の医療施設改善に対する政府の取り組み
  • 移植医療の急速な発展とヒト組織の用途の増加
• 市場抑制要因
  • 管理された環境下での生体組織の保存にかかる高コスト
• 市場機会
  • 医薬品分析の大幅な進歩による組織保存の高度化
  • ヘルスケア分野におけるバイオバンク技術の進歩
• 市場の課題
  • 組織バンキングの限界

ポーターの5つの力：組織バンキング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、組織バンキング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：組織バンキング市場における外部からの影響の把握

外部マクロ環境要因は、組織バンキング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析組織バンキング市場における競合情勢の把握

組織バンキング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス組織バンキング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、組織バンキング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨組織バンキング市場における成功への道筋を描く

組織バンキング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でバイオバンクが増加
    • ヘルスケア機関によるヘルスケア施設の改善に向けた政府の取り組み
    • 移植医療の急速な発展と人体組織の応用の増加
  • 抑制要因
    • 管理された環境下での生物組織の保存には高いコストがかかる
  • 機会
    • 医薬分析の大きな進歩による組織保存のアップグレード
    • ヘルスケア分野におけるバイオバンキング技術の進歩
  • 課題
    • 組織バンキングの制限
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 組織バンキング市場：製品別

• 消耗品
• 装置

第7章 組織バンキング市場：用途別

• 化粧品
• 医学調査
• 治療薬

第8章 組織バンキング市場：エンドユーザー別

• バイオバンク
• 病院・クリニック
• 調査・学術機関

第9章 南北アメリカの組織バンキング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の組織バンキング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの組織バンキング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Beckman Coulter, Inc.
• Bio-Rad Laboratories Inc.
• BioKryo GmbH
• Bluechiip Limited
• Chernobyl Tissue Bank
• Corning Incorporated
• Eli Lilly & Company
• Merck KGaA
• Organ Recovery Systems, Inc.
• Panasonic Corporation
• PHC Holdings Corporation
• QIAGEN N.V.
• Sanofi SA
• Taylor-Wharton International LLC
• Thermo Fisher Scientific Inc.
• VIVEX Biologics, Inc.

LIST OF FIGURES

• FIGURE 1. TISSUE BANKING MARKET RESEARCH PROCESS
• FIGURE 2. TISSUE BANKING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TISSUE BANKING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TISSUE BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TISSUE BANKING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TISSUE BANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TISSUE BANKING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TISSUE BANKING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TISSUE BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TISSUE BANKING MARKET DYNAMICS
• TABLE 7. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TISSUE BANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TISSUE BANKING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TISSUE BANKING MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TISSUE BANKING MARKET SIZE, BY MEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TISSUE BANKING MARKET SIZE, BY BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TISSUE BANKING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TISSUE BANKING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. TISSUE BANKING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. TISSUE BANKING MARKET, FPNV POSITIONING MATRIX, 2023

The Tissue Banking Market was valued at USD 33.81 billion in 2023, expected to reach USD 37.13 billion in 2024, and is projected to grow at a CAGR of 9.91%, to USD 65.54 billion by 2030.

The scope and definition of tissue banking encompass the collection, processing, storage, and distribution of human tissues for therapeutic and research purposes. This process is crucial for applications in regenerative medicine, cancer treatment, and transplantation, as well as serving as a vital resource in biomedical research. Tissue banks play an essential role in ensuring the timely availability of tissues that meet quality and safety standards. The end-use scope includes hospitals, research institutes, and biopharmaceutical companies, each utilizing the tissues for their specific applications, ranging from direct patient care to advanced medical research and the development of novel therapies.

Key growth factors influencing the tissue banking market include advancements in biotechnology, increasing demand for regenerative medicine, and the rising prevalence of chronic diseases necessitating advanced therapeutic solutions. Government initiatives promoting tissue-based research and increasing R&D investments by pharmaceutical companies further bolster this growth. Notable opportunities lie in expanding emerging markets, underscored by improving healthcare infrastructure and growing tissue donation awareness. To capitalize, businesses should focus on developing cost-effective and efficient tissue preservation techniques, enhancing the reliability of tissue-engineered products, and forming strategic partnerships with academic and research institutions.

Challenges affecting market growth include stringent regulatory frameworks governing tissue banking operations and ethical concerns related to tissue donation and usage. Technological hurdles in the preservation and long-term storage of tissues also pose significant challenges. Innovations in cryopreservation methods, automation in tissue processing, and development of bio-banking software for data management present promising areas for research and business growth.

The market is characterized by a complex interplay of regulatory and ethical considerations, mixed with rapid technological advancements. Thus, companies must prioritize compliance with regulatory standards while investing in cutting-edge research and development. Collaboration with regulatory bodies, investment in training, and public awareness campaigns about tissue donation are recommended strategies to foster market expansion and address current limitations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Banking Market

The Tissue Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of bio banks across the globe
  • Government initiatives by healthcare organizations to improvise healthcare facilities
  • Rapid development of transplant medicine and rise in applications of human tissue
• Market Restraints
  • High-cost involved in preservation of biological tissues under controlled environments
• Market Opportunities
  • Upgradation in the storage of tissues owing to the huge progression in medicinal analysis
  • Advancements in biobanking technology in the healthcare sector
• Market Challenges
  • Limitations of tissue banking

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Banking Market

A detailed market share analysis in the Tissue Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Banking Market

A strategic analysis of the Tissue Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Banking Market, highlighting leading vendors and their innovative profiles. These include Beckman Coulter, Inc., Bio-Rad Laboratories Inc., BioKryo GmbH, Bluechiip Limited, Chernobyl Tissue Bank, Corning Incorporated, Eli Lilly & Company, Merck KGaA, Organ Recovery Systems, Inc., Panasonic Corporation, PHC Holdings Corporation, QIAGEN N.V., Sanofi SA, Taylor-Wharton International LLC, Thermo Fisher Scientific Inc., and VIVEX Biologics, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Equipment.
• Based on Application, market is studied across Cosmetics, Medical research, and Therapeutics.
• Based on End User, market is studied across Biobanks, Hospitals & Clinics, and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of bio banks across the globe
    • 5.1.1.2. Government initiatives by healthcare organizations to improvise healthcare facilities
    • 5.1.1.3. Rapid development of transplant medicine and rise in applications of human tissue
  • 5.1.2. Restraints
    • 5.1.2.1. High-cost involved in preservation of biological tissues under controlled environments
  • 5.1.3. Opportunities
    • 5.1.3.1. Upgradation in the storage of tissues owing to the huge progression in medicinal analysis
    • 5.1.3.2. Advancements in biobanking technology in the healthcare sector
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations of tissue banking
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tissue Banking Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Equipment

7. Tissue Banking Market, by Application

• 7.1. Introduction
• 7.2. Cosmetics
• 7.3. Medical research
• 7.4. Therapeutics

8. Tissue Banking Market, by End User

• 8.1. Introduction
• 8.2. Biobanks
• 8.3. Hospitals & Clinics
• 8.4. Research & Academic Institutes

9. Americas Tissue Banking Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Tissue Banking Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Banking Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Beckman Coulter, Inc.
• 2. Bio-Rad Laboratories Inc.
• 3. BioKryo GmbH
• 4. Bluechiip Limited
• 5. Chernobyl Tissue Bank
• 6. Corning Incorporated
• 7. Eli Lilly & Company
• 8. Merck KGaA
• 9. Organ Recovery Systems, Inc.
• 10. Panasonic Corporation
• 11. PHC Holdings Corporation
• 12. QIAGEN N.V.
• 13. Sanofi SA
• 14. Taylor-Wharton International LLC
• 15. Thermo Fisher Scientific Inc.
• 16. VIVEX Biologics, Inc.